Synthetic Bone Graft

November 9, 2021

Graftys Acquires Biologics4Life

Graftys Acquires Biologics4Life
Biologics4Life is developing a injectable synthetic bone graft materials, complementing Graftys' resorbable calcium phosphate cement.
October 14, 2021

Bone Biologics Announces Pricing of Public Offering

Bone Biologics Announces Pricing of Public Offering
Bone Biologics is currently focusing its development efforts for its bone graft substitute product on bone regeneration in spinal fusion.
September 21, 2021

Orthofix Launches Opus Bone Void Filler

Orthofix Launches Opus Bone Void Filler
Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures.
September 8, 2021

Study Update: OssDsign Synthetic Bone Graft

Study Update: OssDsign Synthetic Bone Graft
The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion.
September 7, 2021

Locate Bio Closes £10 Million Funding Round

Locate Bio Closes £10 Million Funding Round
Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products.
August 16, 2021

OssDsign Launches Catalyst Synthetic Bone Graft

OssDsign Launches Catalyst Synthetic Bone Graft
OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries.
July 30, 2021

Bioventus to Acquire Misonix, Enhance Surgical Solutions

Bioventus to Acquire Misonix, Enhance Surgical Solutions
The merger will create a company positioned with products and specialized salesforces serving hospital, ambulatory surgical center and office care settings.
May 21, 2021

Prosidyan Gains CE Mark for FIBERGRAFT Bone Grafts

Prosidyan Gains CE Mark for FIBERGRAFT Bone Grafts
FIBERGRAFT BG Putty, FIBERGRAFT BG Putty GPS and FIBERGRAFT BG Morsels are intended for use in the lumbar and anterior cervical spine.
April 13, 2021

GreenBone Closes a €10 Million Funding

GreenBone Closes a €10 Million Funding
GreenBone Ortho completed a €10 million (USD ~$11.9 million) Series B investment round, bringing the total raised to €22 million (~$26.3 million) since 2015. GreenBone specializes in bone regeneration using a proprietary 3D scaffold made of natural wood-derived materials....
March 30, 2021

Biocomposites Launches Biocomposites Companion App

Biocomposites Launches Biocomposites Companion App
The app puts user information in the hands of healthcare professionals to support STIMULAN and genex at point of use.
February 17, 2021

Paragon 28 Launches MgNum Bone Void Filler

Paragon 28 Launches MgNum Bone Void Filler
MgNum BVF comprises magnesium, phosphates and a proprietary solution. It has 3x the compressive strength of cancellous bone and adhesive properties.
November 2, 2020

Olympus Acquires FH ORTHO

Olympus Acquires FH ORTHO
The acquisition underscores Olympus' plan to expand orthopedic minimally invasive surgery products, both organically and through mergers and acquisitions.
October 6, 2020

Graftys Gains CE Recertification of Bone Void Fillers

Graftys Gains CE Recertification of Bone Void Fillers
Graftys' products are registered in more than 30 countries worldwide, including Europe, the U.S., Canada and South America.
August 26, 2020

SurGenTec Gains FDA Clearance for OsteoFlo NanoPutty

SurGenTec Gains FDA Clearance for OsteoFlo NanoPutty
OsteoFlo NanoPutty bone graft features the world's first quadphasic synthetic bone graft particles with nano-surface technology.
August 24, 2020

Xtant Medical Launches Matriform Si for Spinal Fusion

Xtant Medical Launches Matriform Si for Spinal Fusion
The company announced the U.S. commercial launch of the Matriform Si, a silicated synthetic bone graft substitute designed and cleared for spinal fusion.
June 25, 2020

Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip

Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip
Bioventus received FDA 510(k) clearance to market SIGNAFUSE® Bioactive Bone Graft in a strip format. The strips consist of 55% bioglass by weight and have been shown to induce higher levels of osteoblast differentiation compared to other synthetic bone graft strips....
June 17, 2020

SIRAKOSS Receives FDA Clearance for Osteo3 ZP Putty

SIRAKOSS Receives FDA Clearance for Osteo3 ZP Putty
Osteo3 ZP Putty combines best-in-class bone repair with intraoperative ease-of-use for spine and trauma bone grafting applications.
June 9, 2020

BONESUPPORT Launches Direct Sales in the Netherlands

BONESUPPORT Launches Direct Sales in the Netherlands
BONESUPPORT's bone graft substitutes are based on the patented CERAMENT technology platform. Direct sales commence in July 2020.
April 23, 2020

Biocomposites Granted CE Mark for STIMULAN

Biocomposites Granted CE Mark for STIMULAN
This represents the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue.
April 7, 2020

BBS-Bioactive Bone Substitutes Granted U.S. Patent

BBS-Bioactive Bone Substitutes Granted U.S. Patent
BBS-Bioactive Bone Substitutes' patent application protecting ARTEBONE® bone graft substitute has been accepted in the U.S. 
March 18, 2020

Kuros Strengthens Orthobiologics Patent Portfolio

Kuros Strengthens Orthobiologics Patent Portfolio
Kuros Biosurgery was granted U.S. patents related to the MagnetOs product line and parathyroid hormones containing matrices for spinal fusion.
March 18, 2020

Renovos to Develop Next-Gen Technology to “Tame” BMP-2 Diffusion

Renovos to Develop Next-Gen Technology to “Tame” BMP-2 Diffusion
Regenerative medicine is an emerging market with solutions to not only heal but also grow tissue and bone. Renovos is addressing the issue of biological molecule diffusion through a synthetic nanoclay gel technology platform called Renovite.
March 4, 2020

Biocomposites Launches STIMULAN Rapid Cure 3cc

Biocomposites Launches STIMULAN Rapid Cure 3cc
Biocomposites commenced U.S. launch of STIMULAN® Rapid Cure 3cc synthetic calcium sulfate, designed specifically for smaller voids in the foot and ankle.
December 10, 2019

Anika Fully Launches TACTOSET in the U.S.

Anika Fully Launches TACTOSET in the U.S.
Anika Therapeutics is commencing full U.S. commercial launch of TACTOSET surgically-delivered therapy for bone repair procedures.
December 3, 2019

Biomatlante Acquired by Advanced Medical Solutions

Biomatlante Acquired by Advanced Medical Solutions
Advanced Medical Solutions acquired Biomatlante, developer, and manufacturer of orthobiologic products with application in joint reconstruction, spine, trauma, and sports medicine procedures.
October 22, 2019

ARTEBONE Patent Application Accepted in Canada

BBS-Bioactive Bone Substitutes' patent application regarding a bone protein preparation has been accepted in Canada.
March 28, 2019

FzioMed Enrolls 50th Patient in Oxiplex Study

FzioMed reached a milestone of 1/3 patient enrollment in a clinical study of Oxiplex® gel for reduction of pain following partial discectomy.
March 22, 2019

Graftys Completes Capital Raise for Expansion

Graftys completed a ‚¬4.1MM (~US $4.6MM) funding round. Proceeds will support commercialization of QuickSet cement and HBS injectable calcium phosphate bone graft substitute.
January 31, 2019

SIRAKOSS Osteo3 Gains CE Mark

SIRAKOSS received approval under the CE Mark for Osteo3 nanosynthetic bone graft substitute.
November 19, 2018

Innovasis Signs Private-Label Agreement with Stability Biologics

Innovasis entered into a private-label agreement with Stability Biologics that includes access to Physio® bone allograft. Product launch is expected by year-end.
September 28, 2018

Kuros Biosciences: First Procedure in MagnetOS Spinal Fusion Trial

The first patient has been treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in spinal fusion.
September 21, 2018

Synergy Biomedical Launches BIOSPHERE MIS PUTTY

Synergy Biomedical received FDA 510(k) clearance and commenced full launch of BIOSPHERE® MIS PUTTY for open, mini-open and percutaneous minimally invasive procedures.
August 16, 2018

BONESUPPORT’s CERAMENT G Approved by Health Canada

BONESUPPORT received regulatory approval from Health Canada for CERAMENT® G gentamicin-eluting injectable ceramic bone graft substitute.
May 10, 2018

DePuy Synthes, Prosidyan Partner on FIBERGRAFT Products

DePuy Synthes entered into an exclusive agreement to promote Prosidyan's FIBERGRAFT® synthetic bone graft in spinal fusion, starting in 2Q18.
March 14, 2018

Cerapedics Launching IDE Study of P-15L Bone Graft in TLIF

Cerapedics received FDA approval for an IDE clinical trial of P-15L Peptide Enhanced Bone Graft vs. autograft in TLIF to treat degenerative disc disease.
March 8, 2018

Ortho RTi Receives Notice of Allowance for European Patent

Ortho Regenerative Technologies received an EU Notice of Allowance for a patent that will protect the composition of Ortho-R biopolymer for soft tissue repair.
March 6, 2018

Synergy Biomedical Launching BIOSPHERE PUTTY in Australia

Synergy Biomedical received Therapeutic Goods Administration clearance and commenced launch of BIOSPHERE PUTTY bioactive bone graft in Australia.
February 28, 2018

Biomatlante’s MBCP Matrix Selected for Fracture Study

Biomatlante's MBCP+ synthetic bone graft matrix has been selected for comparison to autograft in a 5-year trial in the treatment of long bone nonunions.
February 27, 2018

Leader Biomedical Acquires International Orthopaedics

Leader Biomedical is acquiring International Orthopaedics, manufacturer of ICON total hip and hip resurfacing implants and instruments. 
January 11, 2018

ReBOSSIS Bone Scaffold Gains FDA Clearance in Spine

ORTHOReBIRTH USA received FDA 510(k) clearance to market ReBOSSIS® biosynthetic bone scaffold for use in posterolateral spine procedures.
October 23, 2017

Artoss Launching NanoBone QD Bone Graft

Artoss introduced NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery.
October 3, 2017

Vivorte Launches New Bone Graft Products

Vivorté launched FORTERA™ and REGENTO™ bone graft products for orthopaedic surgery.
June 27, 2017

ChoiceSpine Launches Biologics Portfolio

ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware portfolio.
May 25, 2017

SurGenTec Receives US Patent for GRAFTGUN

SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® device.
March 8, 2017

Bioactive Glass Shown Effective Towards Antibiotic-resistant Bacteria

Studies of BonAlive® indicate that the naturally-antibacterial bioactive glass yields excellent results in the treatment of osteomyelitis, without the use of local antibiotics.
January 26, 2017

Sirakoss Receives US Patents for Bone Graft Technologies

SIRAKOSS was granted two U.S. patents covering synthetic bone graft technologies, and seeks to raise £3.5MM to £5.0MM in support of U.S. and EU regulatory approvals.
December 14, 2016

Zimmer Biomet Launches PrimaGen Advanced Allograft

Zimmer Biomet launched PrimaGen Advanced™ Allograft, an autograft substitute comprising cancellous bone + demineralized cortical bone fibers with verified osteoinductivity.
December 9, 2016

Study Results: Biomatlante’s MBCP+ Synthetic Bone Graft and MSCs

Study results demonstrated a high rate of clinical success from a combination of Biomatlante's MBCP+™ synthetic bone graft plus mesenchymal stem cells, particularly in the treatment of long bone non-union fractures.
December 8, 2016

curasan Receives FDA Clearance for CERASORB Ortho FOAM

curasan received FDA 510(k) clearance to market CERASORB Ortho FOAM synthetic bone material for the treatment of bone defects in the extremities and pelvis. 
October 27, 2016

BONESUPPORT Raises $37MM to Support Cerament

BONESUPPORT raised SEK 327MM (~US $37MM). Funds will support clinical data collection, product pipeline development and expansion of CERAMENT sales in existing and new markets.
August 9, 2016

BONESUPPORT Receives FDA Approval to Initiate IDE Clinical Study

BONESUPPORT received FDA approval to launch an Investigational Device Exemption study of CERAMENT G bone graft substitute in the treament of open diaphyseal tibial fractures.
June 1, 2016

Pre-Clinical Study Highlights CERAMENT’s Bone Remodeling Properties

Pre-clinical study results demonstrated that BONESUPPORT's CERAMENT™, loaded with rhBMP-2 + zoledronic acid in very low doses, was able to quantitatively/qualitatively generate a high amount of mineralized bone volume.
May 23, 2016

NuVasive Announces U.S. Launch of AttraX® Putty

NuVasive announced the U.S. launch of AttraX® Putty, a synthetic bone graft for use in the posterior lateral spine.
May 12, 2016

Tecres and Keensight to Form Demetra

Demetra Holding has formed with investment from Tecres and Keensight, which acquired aap Implantate's biomaterials assets. 
May 4, 2016

Orthocell Gains approval for Collagen Scaffold Study

Orthocell was granted ethical approval in Australia for a clinical study of a microfracture technique using the Celgro SMRT Graft collagen scaffold.
April 28, 2016

New Product Launches from NuVasive

NuVasive announced launch of new products such as AttraX® Putty Biotextured™ bone graft, the Reline® Modular system, next-gen MAS® TLIF 2 technology, etc.
April 21, 2016

Bone Solutions Signs Distribution Agreement with Next Health

Bone Solutions signed an exclusive 10-state U.S. distribution agreement with Next Health for OsteoCrete magnesium-based bone graft substitute.
March 1, 2016

BONESUPPORT Launches CERAMENT|G 5 mL in the EU

BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU to support small joint and extremity indications.
February 2, 2016

BONESUPPORT Expands CERAMENT Procedure Registry

BONESUPPORT expanded its 2014 injectable bone substitute registry to include 230 CERAMENT™ G procedures, as well as procedures involving the CERAMENT V formulation. 
January 11, 2016

20,000 Patients Treated with BONESUPPORT’s CERAMENT

BONESUPPORT announced the milestone of >20,000 patients treated worldwide to date with CERAMENT™ injectable drug-eluting bone substitute products.